MindWalk Holdings (HYFT) Retained Earnings (2020 - 2026)
MindWalk Holdings (HYFT) posted quarterly Retained Earnings of -$104.1 million for Q2 2026, down 15.05% year-over-year from -$122.6 million in Q2 2025, and down 4.07% quarter-over-quarter from -$100.1 million in Q1 2026.
MindWalk Holdings (HYFT) Retained Earnings (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported Retained Earnings for 7 consecutive years, with -$104.1 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Retained Earnings fell 15.05% year-over-year to -$104.1 million; the TTM figure through Apr 2026 stood at -$104.1 million (down 15.05% YoY), while the FY2026 annual figure was -$104.1 million, down 12.62% from the prior year.
- Retained Earnings fell to -$104.1 million in Q2 2026 per HYFT's latest filing, from -$100.1 million in the prior quarter.
- Across five years, Retained Earnings topped out at -$33.1 million in Q1 2022 and bottomed at -$104.1 million in Q2 2026.
- Historically, Retained Earnings has averaged -$69.1 million across 5 years, with a median of -$66.8 million in 2024.
- Annual changes were most pronounced in 2022 — Retained Earnings tumbled 71.76% — and 2026, when it decreased 12.17%.
- MindWalk Holdings' Retained Earnings stood at -$47.6 million in 2022, then dropped by 22.76% to -$58.5 million in 2023, then plunged by 31.65% to -$77.0 million in 2024, then fell by 26.37% to -$97.3 million in 2025, then dropped by 7.05% to -$104.1 million in 2026.
- Business Quant data shows HYFT's Retained Earnings at -$104.1 million in Q2 2026, -$100.1 million in Q1 2026, and -$97.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | 5.13 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -104.13 Mn |
| Jan 31, 2026 | -100.06 Mn |
| Oct 31, 2025 | -97.27 Mn |
| Jul 31, 2025 | -95.89 Mn |
| Apr 30, 2025 | -90.51 Mn |
| Jan 31, 2025 | -89.20 Mn |
| Oct 31, 2024 | -76.97 Mn |
| Jul 31, 2024 | -74.90 Mn |
| Apr 30, 2024 | -72.69 Mn |
| Jan 31, 2024 | -60.82 Mn |
| Oct 31, 2023 | -58.47 Mn |
| Jul 31, 2023 | -57.43 Mn |
| Apr 30, 2023 | -54.02 Mn |
| Jan 31, 2023 | -50.38 Mn |
| Oct 31, 2022 | -47.63 Mn |
| Jul 31, 2022 | -43.47 Mn |
| Apr 30, 2022 | -36.74 Mn |
| Jan 31, 2022 | -33.09 Mn |
| Oct 31, 2021 | -30.27 Mn |
| Jul 31, 2021 | -26.90 Mn |